Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease

Brain. 2024 Nov 12:awae335. doi: 10.1093/brain/awae335. Online ahead of print.

Omar Chuquisana¹, Marianna Spatola^{2

3}, Alessandro Dinoto⁴, María Sepúlveda^{2

3}, Sara Mariotto⁴, Mar Tintore^{5

6}, Xavier Montalban^{5

6}, Manuel Comabella^{5

6}, Jan D Lünemann¹

¹ Department of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, NRW, Germany.
² Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, 08036 Barcelona, BCN, Spain.
³ La Caixa Research Institute, 08035 Barcelona, BCN, Spain.
⁴ Neurology Unit, Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona, 37129 Verona, VR, Italy.
⁵ Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona. 08035 Barcelona, BCN, Spain.
⁶ Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), 08500 Vic, BCN, Spain.

No abstract available